Abstract
Serum levels of mammary serum antigen (MSA) and CA15-3 were evaluated in 135 individuals in order to determine their single and combined value in the diagnosis and monitoring of breast cancer. Raised MSA levels (greater than 300 IU) were found in 68% of patients with Stage I and II breast cancer compared to only 3% having raised CA15-3 levels (greater than 40 U ml-1). Of 38 patients with Stage IV breast cancer, 95% had raised levels of MSA and CA15-3 combined with each test individually detecting 82% of those with Stage IV disease. No correlation was found between MSA and CA15-3 levels. Four patients being treated for breast cancer were followed over a 5-17 week period; MSA levels correlated with disease course in 3 and CA-15 in 2. The overall sensitivity, specificity and accuracy in detecting breast cancer were 76%, 91% and 96% for MSA; and 47%, 95% and 97% for CA15-3 respectively. When both tests were used together combined evaluation gave the highest sensitivity (84%) and specificity (100%). MSA seems to be superior to CA15-3 for early breast cancer diagnosis and a combination of the two tests gave the best results for metastatic disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sacks, N., Stacker, S., Thompson, C. et al. Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer. Br J Cancer 56, 820–824 (1987). https://doi.org/10.1038/bjc.1987.297
Issue Date:
DOI: https://doi.org/10.1038/bjc.1987.297
This article is cited by
-
CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancer
Breast Cancer Research and Treatment (1995)
-
Immunosuppressive acidic protein serum levels in breast cancer patients in a reference to CA 15-3 levels
Breast Cancer Research and Treatment (1994)
-
Mammary serum antigen (MSA) in advanced breast cancer
Breast Cancer Research and Treatment (1990)
-
CEA and CA 15-3 in primary and recurrent breast cancer
World Journal of Surgery (1990)
-
Mucin-like cancer-associated antigen (MCA) compared with CA 15-3 in advanced breast cancer
Klinische Wochenschrift (1989)